These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2452122

  • 21. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma.
    Tanabe Y, Ohnishi K, Nomura F, Iida S.
    Am J Gastroenterol; 1988 Dec; 83(12):1386-9. PubMed ID: 2461655
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F.
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [Abstract] [Full Text] [Related]

  • 23. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T, Sawada T, Kita J, Iso Y, Kato M, Rokkaku K, Shimoda M, Kubota K.
    Hepatogastroenterology; 2008 Mar; 55(86-87):1705-9. PubMed ID: 19102374
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
    Tatsuta M, Yamamura H, Iishi H, Kasugai H, Okuda S.
    Oncology; 1986 Mar; 43(5):306-10. PubMed ID: 2429242
    [Abstract] [Full Text] [Related]

  • 26. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R, Leuci D, Tortorella C, Fiore G, Marinosci F, Schiraldi O, Antonaci S.
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD.
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of combined assays of serum ferritin, alpha-1-antitrypsin and alpha-fetoprotein in liver cancer.
    Tang DJ, Lang YM, Feng YZ.
    Chin Med J (Engl); 1992 Nov; 105(11):900-4. PubMed ID: 1284788
    [Abstract] [Full Text] [Related]

  • 29. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF.
    Nutr Cancer; 2010 Nov; 62(2):190-7. PubMed ID: 20099193
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 Nov; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 32. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741
    [Abstract] [Full Text] [Related]

  • 33. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
    Kim J, Ki SS, Lee SD, Han CJ, Kim YC, Park SH, Cho SY, Hong YJ, Park HY, Lee M, Jung HH, Lee KH, Jeong SH.
    Am J Gastroenterol; 2006 Sep 22; 101(9):2051-9. PubMed ID: 16848813
    [Abstract] [Full Text] [Related]

  • 34. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 22; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 35. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K, Magario N, Yokoo T, Naraki T.
    Cancer; 1999 Feb 15; 85(4):812-8. PubMed ID: 10091758
    [Abstract] [Full Text] [Related]

  • 36. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
    Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.
    Am J Gastroenterol; 2006 Sep 15; 101(9):2038-43. PubMed ID: 16848811
    [Abstract] [Full Text] [Related]

  • 37. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
    Furui J, Furukawa M, Kanematsu T.
    Hepatogastroenterology; 1995 Sep 15; 42(5):445-9. PubMed ID: 8751193
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 40. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report.
    Fujiwara Y, Takenaka K, Kajiyama K, Maeda T, Gion T, Shirabe K, Shimada M, Sugimachi K.
    Hepatogastroenterology; 1997 Oct 15; 44(15):820-3. PubMed ID: 9222698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.